Bionexus
Private Company
Funding information not available
Overview
Bionexus is a private, revenue-generating biotechnology services and products company that caters primarily to the research tools and contract research organization (CRO) markets. Its business model integrates the sale of consumables (like DNA markers and buffers), benchtop laboratory instruments, and a wide array of molecular biology and immunology services, including gene synthesis, library construction, and custom plasmid production. The company positions itself as a customer-centric provider, delivering products and services directly from its manufacturing sites. While not a therapeutic developer, Bionexus supports the broader biotech R&D ecosystem from academic labs to biopharma companies.
Technology Platform
Integrated service and supply chain ecosystem for molecular biology, genomics, and immunology research, combining e-commerce product sales with fee-for-service contract research capabilities.
Opportunities
Risk Factors
Competitive Landscape
Bionexus competes in the fragmented life science tools and CRO market. Major competitors include global giants like Thermo Fisher Scientific, Merck KGaA, and Danaher, which offer vast product catalogs and some services. It also competes with specialized service CROs like GenScript, Twist Bioscience (for gene synthesis), and numerous smaller boutique firms. Differentiation relies on customer service, technical expertise, and integrated product-service bundles.